The primary validation study was undertaken in 152 patients with Rheumatoid Arthritis in the UK.
Patients were administered the VOLP. Half of patients then randomised to complete work diary for 2 weeks (for reliability). Patients then completed a follow-up questionnaire based on the VOLP.
The objectives of the study were:
Reference